MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer

European Journal of Cancer

Volumn 46, Issue 8, 2010, Pages 1456-1463

  Lai, Kin Wai ^a   Koh, King Xin ^a   Loh, Marie ^a   Tada, Kotaro ^a   Subramaniam, Manish Mani ^a   Lim, Xn Yii ^a   Vaithilingam, Aparna ^a   Salto Tellez, Manuel ^a,b   Iacopetta, Barry ^c   Ito, Yoshiaki ^a   Soong, Richie ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Epigenetics; Gastric cancer; MicroRNA; miR 130b; RUNX3; Tumour suppressor

Indexed keywords

BIM PROTEIN; MICRORNA; MICRORNA 130B; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; RUNX3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METHYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH; STOMACH CANCER; WESTERN BLOTTING; ALGORITHM; DOWN REGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ALGORITHMS; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; STOMACH NEOPLASMS;

EID: 77951666669     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.01.036     Document Type: Article

References (30)

1. Ito K., Lim A.C., Salto-Tellez M., et al. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell 14 3 (2008) 226-237
2. Li Q.L., Ito K., Sakakura C., et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109 1 (2002) 113-124
3. Vogiatzi P., De Falco G., Claudio P.P., and Giordano A. How does the human RUNX3 gene induce apoptosis in gastric cancer? Latest data, reflections and reactions. Cancer Biol Ther 5 4 (2006) 371-374
4. Chi X.Z., Yang J.O., Lee K.Y., et al. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol Cell Biol 25 18 (2005) 8097-8107
5. Yano T., Ito K., Fukamachi H., et al. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol Cell Biol 26 12 (2006) 4474-4488
6. Soong R., Shah N., Peh B.K., et al. The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome. Br J Cancer 100 5 (2009) 676-679
7. Subramaniam M.M., Chan J.Y., Soong R., et al. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression. Breast Cancer Res Treat 113 1 (2009) 113-121
8. Yoshizaki T., Enomoto T., Fujita M., et al. Frequent inactivation of RUNX3 in endometrial carcinoma. Gynecol Oncol 110 3 (2008) 439-444
9. Gao F., Huang C., Lin M., et al. Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas. J Cancer Res Clin Oncol 135 5 (2009) 739-747
10. Sakakura C., Miyagawa K., Fukuda K.I., et al. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis. Oncogene 26 40 (2007) 5927-5938
11. Sugiura H., Ishiguro H., Kuwabara Y., et al. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Oncol Rep 19 3 (2008) 713-719
12. Ito K., Liu Q., Salto-Tellez M., et al. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 65 17 (2005) 7743-7750
13. Fujii S., Ito K., Ito Y., and Ochiai A. Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation. J Biol Chem 283 25 (2008) 17324-17332
14. Xiao W.H., and Liu W.W. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 10 3 (2004) 376-380
15. Lagos-Quintana M., Rauhut R., Lendeckel W., and Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 294 5543 (2001) 853-858
16. Brodersen P., and Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 10 2 (2009) 141-148
17. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10 10 (2009) 704-714
18. Johnson S.M., Grosshans H., Shingara J., et al. RAS is regulated by the let-7 microRNA family. Cell 120 5 (2005) 635-647
19. Meng F., Henson R., Wehbe-Janek H., et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 2 (2007) 647-658
20. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., and Enright A.J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34 database issue (2006) D140-D144
21. Soong R., and Iacopetta B.J. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors. Mod Pathol 10 3 (1997) 252-258
22. Weisenberger D.J., Siegmund K.D., Campan M., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38 7 (2006) 787-793
23. Kuhn D.E., Martin M.M., Feldman D.S., et al. Experimental validation of miRNA targets. Methods 44 1 (2008) 47-54
24. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103 7 (2006) 2257-2261
25. Talotta F., Cimmino A., Matarazzo M.R., et al. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28 1 (2009) 73-84
26. Zhang Z., Li Z., Gao C., et al. MiR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88 12 (2008) 1358-1366
27. Liu T., Tang H., Lang Y., Liu M., and Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 273 2 (2009) 233-242
28. Kim T.Y., Lee H.J., Hwang K.S., et al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 84 4 (2004) 479-484
29. Kim Y.K., Yu J., Han T.S., et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37 5 (2009) 1672-1681
30. Kitago M., Martinez S.R., Nakamura T., Sim M.S., and Hoon D.S. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. Clin Cancer Res 15 9 (2009) 2988-2994